Flu-Bu-Mel Conditioning Regimen for Myeloid Disease
NCT04269811
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Relapse Rate After Allo-HSCT
Interventions
DRUG:
Flu-Bu-Mel
Sponsor
Shanghai Jiao Tong University School of Medicine